Discontinued — last reported Q4 '24
Biogen Net investment gains (losses) decreased by 686.8% to -$22.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 162.6%, from $35.60M to -$22.30M. This is a positive signal — higher values indicate stronger performance for this metric.
Gains indicate strong performance of financial assets, while losses suggest market downturns or poor investment strategy execution.
This captures the realized and unrealized changes in the fair value of the company's investment portfolio, including equ...
Standard for companies with large treasury departments or captive finance arms.
investment_gains_losses| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $154.30M | $424.20M | $190.70M | $77.20M | -$109.80M | $78.10M | -$106.50M | $302.00M | $30.60M | $30.40M | -$39.10M | $35.60M | -$5.30M | $3.80M | -$22.30M |
| QoQ Change | — | +174.9% | -55.0% | -59.5% | -242.2% | +171.1% | -236.4% | +383.6% | -89.9% | -0.7% | -228.6% | +191.0% | -114.9% | +171.7% | -686.8% |
| YoY Change | — | — | — | -50.0% | -125.9% | -59.0% | -238.0% | +375.0% | -60.8% | +128.5% | -112.9% | +16.3% | -117.4% | +109.7% | -162.6% |